Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
New Drug ApprovalFDA Approves Onapgo (Apomorphine Hydrochloride) for Treating Motor Fluctuations in Advanced Parkinson’s diseaseWritten and Reviewed by Team Pharmacally Introduction The U.S. Food and Drug Administration (FDA) has recently given the green light…Fact-Checked
New Drug ApprovalA New Hope for Crohn’s Patients: Eli Lilly’s Omvoh Gains FDA Approval”Written and Reviewed by Team Pharmacally On January 15, 2025, the U.S. Food and Drug Administration (FDA) granted approval to…Fact-Checked
New Drug ApprovalBreaking Barriers in Lung Cancer Treatment: The Impact of LorlatinibWritten and Reviewed by Team Pharmacally Lung cancer is one of the most prevalent and deadly forms of cancer worldwide.Fact-Checked
New Drug ApprovalA New Development in Immunotherapy for the Treatment of Nasopharyngeal Carcinoma: FDA Approves LOQTORZIWritten and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) has approved LOQTORZI (generic name: Lacnozalimab), a…Fact-Checked
New Drug ApprovalBreaking Barriers in Breast Cancer: Enhertu Shows Promise for HER2-Low PatientsWritten and Reviewed by Team Pharmacally For patients with HER2-low breast cancer, the medication Enhertu (fam-trastuzumab deruxtecan-nxki) has shown remarkable…Fact-Checked
New Drug ApprovalEMA Grants Marketing Authorization for Emcitate (Tiratricol) for Peripheral Thyrotoxicosis in MCT8 Deficiency (Allan-Herndon-Dudley Syndrome)Written and Reviewed by Team Pharmacally Introduction The European Medicines Agency (EMA) has recently approved Emcitate (tiratricol), a revolutionary treatment…Fact-Checked
New Drug ApprovalAbbVie’s Emblaveo Receives FDA Approval for Treating Complicated Intra-Abdominal InfectionsWritten and Reviewed by Team Pharmacally AbbVie, a leading company in the biopharmaceutical sector, has announced that the U.S. Food…Fact-Checked
New Drug ApprovalSentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) for Menkes DiseaseWritten and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) have accepted Sentynl Therapeutics’ New Drug Application…Fact-Checked
New Drug ApprovalBavarian Nordic’s Chikungunya Vaccine “Vimkunya” Receives Landmark EMA and FDA Approval for Ages 12+Written and Reviewed by Team Pharmacally Bavarian Nordic A/S, a prominent biotechnology firm focused on vaccine development, has reached a…Fact-Checked
New Drug ApprovalCASGEVY: Revolutionizing Gene Therapy with CRISPR Technology to treat Transfusion-Dependent Beta ThalassemiaWritten and Reviewed by Team Pharmacally Introduction Casgevy (exagamglogene autotemcel) is a breakthrough in gene therapy and precision medicine.Fact-Checked
New Drug ApprovalMerus’s Bizengri: A Breakthrough finding in metastatic or advanced non-small cell lung cancer (NSCLC) and advanced unresectable or metastatic pancreatic adenocarcinomaWritten and Reviewed by Team Pharmacally Bizengri, created by Merus N.V., is a potential development in the fast developing field…Fact-Checked
New Drug Approval“Bleeding No More: FDA Approval of Alhemo Signals Hope for Haemophilia Patients”Written and Reviewed by Team Pharmacally The US FDA has granted approval for the Alhemo (concizumab-mtci) injection to be administered…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.